Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Ask the chart: “Has this stock recovered from similar drawdowns before?”
AI equity note (bull/bear, numbers, sources) — coming soon
Management guidance consistency — coming soon
Latest filings
NSE announcements · newest firstSchedule of meet with Analysts/Investors dated September 29, 2026.
Schedule of meet with Analysts/Investors dated September 28, 2026.
Regulation 31A(8)(C) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Schedule of meet with Analyst/Investors dated September 23, 2026.
Key MetricsFull financials →
P/E (TTM)
59.0×
EPS ₹9.47
P / Book
4.33×
BVPS ₹129
ROE
7.6%
FY26, avg equity
Net margin
3.0%
FY26
Revenue YoY
+16.2%
Q4 FY26
Net profit YoY
+21729.4%
Q4 FY26
Debt / equity
0.06×
₹470 Cr debt
Div. yield
–
no dividend in 12 months
From NSE filings (standalone) and the last close.
Shareholding Pattern Jun 2026
Promoter pledge: none reported
Peer Comparison
| Company | P/E | P/B | ROE | Margin |
|---|---|---|---|---|
| ICICIGI₹77,572 Cr | 31.9× | 4.57× | 17.8% | 9.1% |
| GICRE₹59,211 Cr | 6.7× | 0.97× | 17.9% | 21.8% |
| STARHEALTH₹32,842 Cr | 59.0× | 4.33× | 7.6% | 3.0% |
| NIACL₹29,104 Cr | 40.6× | 1.19× | 5.7% | 2.8% |
| GODIGIT₹23,457 Cr | 47.6× | 4.95× | 12.1% | 4.8% |
| NIVABUPA₹14,261 Cr | 109.0× | 3.75× | 3.4% | 1.5% |
General Insurance: the companies closest in market value, of the 6 in that basic industry whose filings we hold. Computed from each company's NSE filings (up to Q4 FY26) and the last close; hover a column for its definition.
Forensic Flags
No check is outside its threshold.
10 checks within their thresholds
Operating cash flow was 2.70× net profit
Cumulative over FY25–FY26 (2 years).
Free cash flow was negative in 0 of the last 2 years
Operating cash flow less capital expenditure, as filed.
Debt to equity is 0.06×
As at 2026-03-31.
Other income is 1% of profit before tax
FY26.
Exceptional items above 5% of pre-tax profit in 0 of the last 2 years
FY25–FY26.
Effective tax rate averaged 26%
Tax over pre-tax profit, last 2 years. The base corporate rate is about 25%.
Promoter holding is 58.01%, -0.03 points over a year
2026-06-30 against 2025-06-30.
No promoter shares are pledged
Shareholding pattern as at 2026-06-30.
No auditor change or resignation filings in three years
From NSE announcements on record.
Results were filed late in 0 of the last 5 quarters
Slowest filing came 30 days after the period end.
Computed from NSE filings (standalone). Colours follow fixed thresholds, shown on hover. These are facts about the filings, not advice. 3 checks not run for lack of data.
Formula Scores
Piotroski F-score: not computed · FY to 2026-03-31the tests use working capital and gross margin, which a bank's or insurer's statements do not have
Altman Z-score: not computed · FY to 2026-03-31not defined for a bank's or insurer's balance sheet
Graham number: 165.78 ₹ per share · FY to 2026-03-31√(22.5 × earnings per share × book value per share): the price at which P/E × P/B = 22.5 (a P/E of 15 at a P/B of 1.5)
- earnings per share: 9.47
- book value per share: 128.98 — owners' equity over shares (paid-up capital / face value)
Inputs: earnings per share 9.47 (2026-03-31) · owners' equity ₹7,589 Cr (2026-03-31) · paid-up capital ₹588 Cr (2026-03-31) · face value 10 (2026-03-31)
a number the book uses as a ceiling for a defensive investor's purchase price; it is arithmetic on two reported figures, not a valuation
Source: Benjamin Graham, The Intelligent Investor (1949; the 22.5 in the 1973 edition's criteria for the defensive investor)
Sloan accrual ratio: not computed · FY to 2026-03-31operating cash flow is not comparable for a bank or insurer
Each score is its published formula applied to the company's own filings (standalone); open one for the tests, the inputs and the paper. Arithmetic on the filings, not a view on the stock.